Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
41105600
NACRES:
NA.54
Specific activity:
≥30 U/mg
Biological source:
bovine pancreas
Concentration:
10 mg/mL
biological source
bovine pancreas
form
solution
specific activity
≥30 U/mg
packaging
pkg of 1 mg (10 mg/ml)
manufacturer/tradename
Roche
concentration
10 mg/mL
General description
A heterogeneous mixture of ribonucleases specially prepared to be free of deoxyribonuclease activity according to the current Quality Control procedures.
Application
High concentration, DNase-free RNase has been used for:
- Genomic DNA isolation
- Isolation of plasmid DNA
- Degradation of RNA for flow cytometry
Preparation Note
Working concentration: 50 μg/ml is the recommended working concentration of RNase, DNase-free, for the isolation of genomic DNA.
Working solution: Recommended in dilution buffer: 10 mM Tris-HCl, 5 mM CaCl2, 50% glycerol (v/v), pH 7.0
Working solution: Recommended in dilution buffer: 10 mM Tris-HCl, 5 mM CaCl2, 50% glycerol (v/v), pH 7.0
Analysis Note
Absence of DNase activity tested according to the current Quality Control procedures.
Other Notes
For life science research only. Not for use in diagnostic procedures.
One unit is the enzyme activity that causes a decrease in absorbance of A0 to A1 within 1 minute under assay conditions: A0 to A1 corresponds to the total conversion, A1 being the final absorbance.
Unlike most RNase preparations, no boiling before use is necessary to remove DNase activity.
signalword
Danger
hcodes
Hazard Classifications
Resp. Sens. 1
Storage Class
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
does not flash
flash_point_c
does not flash
Regulatory Information
低风险生物材料
动植物源性产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E, et al.
Cell, 146(6) (2011)
Diana Pacheco Sousa et al.
STAR protocols, 3(4), 101916-101916 (2023-01-04)
This protocol describes the synthesis and characterization of gold nanoparticle-based nanobeacons as a theranostic strategy for the recognition, detection, and inhibition of miRNA and mRNA. This system is designed for an in vitro evaluation of a sequence's silencing potential and later
Alba Font-Tello et al.
Nature protocols, 15(8), 2503-2518 (2020-06-28)
Fixed-tissue ChIP-seq for H3K27 acetylation (H3K27ac) profiling (FiTAc-seq) is an epigenetic method for profiling active enhancers and promoters in formalin-fixed, paraffin-embedded (FFPE) tissues. We previously developed a modified ChIP-seq protocol (FiT-seq) for chromatin profiling in FFPE. FiT-seq produces high-quality chromatin
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 11579681001 | 04061838703620 |